TY - JOUR
T1 - segcsvdWMH: A Convolutional Neural Network-Based Tool for Quantifying White Matter Hyperintensities in Heterogeneous Patient Cohorts
AU - Gibson, Erin
AU - Ramirez, Joel
AU - Woods, Lauren Abby
AU - Ottoy, Julie
AU - Berberian, Stephanie
AU - Scott, Christopher J M
AU - Yhap, Vanessa
AU - Gao, Fuqiang
AU - Coello, Roberto Duarte
AU - Valdes Hernandez, Maria
AU - Lang, Anthony E
AU - Tartaglia, Carmela M
AU - Kumar, Sanjeev
AU - Binns, Malcolm A
AU - Bartha, Robert
AU - Symons, Sean
AU - Swartz, Richard H
AU - Masellis, Mario
AU - Singh, Navneet
AU - Moody, Alan
AU - MacIntosh, Bradley J
AU - Wardlaw, Joanna M
AU - Black, Sandra E
AU - Lim, Andrew S P
AU - Goubran, Maged
AU - ONDRI Investigators, ADNI, CAIN Investigators, colleagues from the Foundation Leducq Transatlantic Network of Excellence
N1 - © 2024 The Author(s). Human Brain Mapping published by Wiley Periodicals LLC.
PY - 2024/12/26
Y1 - 2024/12/26
N2 - White matter hyperintensities (WMH) of presumed vascular origin are a magnetic resonance imaging (MRI)-based biomarker of cerebral small vessel disease (CSVD). WMH are associated with cognitive decline and increased risk of stroke and dementia, and are commonly observed in aging, vascular cognitive impairment, and neurodegenerative diseases. The reliable and rapid measurement of WMH in large-scale multisite clinical studies with heterogeneous patient populations remains challenging, where the diversity of imaging characteristics across studies adds additional complexity to this task. We present segcsvd
WMH, a convolutional neural network-based tool developed to provide reliable and accurate WMH quantification across diverse clinical datasets. segcsvd
WMH was developed using a large dataset consisting of over 700 fluid-attenuated inversion recovery MRI scans from seven multisite studies, spanning a wide range of clinical populations, WMH burdens, and imaging protocols. Model training incorporated anatomical information through a novel hierarchical segmentation approach, together with extensive data augmentation techniques to improve performance across varied imaging conditions. Benchmarked against three widely available segmentation tools, segcsvd
WMH demonstrated superior accuracy, achieving mean Dice score improvements of 7.8% ± 9.7% over HyperMapp3r, 21.8% ± 8.6% over SAMSEG, and 43.5% ± 7.1% over WMH-SynthSeg across four diverse test datasets. segcsvd
WMH also maintained consistently high Dice scores across these test datasets (mean DSC = 0.86 ± 0.08), and exhibited strong, stable correlations with periventricular, deep, and total WMH ground truth volumes (mean r = 0.99 ± 0.01). Additionally, segcsvd
WMH was robust to low and moderate levels of simulated MRI spike noise artifacts and maintained strong performance across a range of binary segmentation thresholds and WMH burden levels. These findings suggest that segcsvd
WMH may provide more accurate and robust WMH segmentation performance for heterogeneous clinical datasets characterized by varying degrees of CSVD severity.
AB - White matter hyperintensities (WMH) of presumed vascular origin are a magnetic resonance imaging (MRI)-based biomarker of cerebral small vessel disease (CSVD). WMH are associated with cognitive decline and increased risk of stroke and dementia, and are commonly observed in aging, vascular cognitive impairment, and neurodegenerative diseases. The reliable and rapid measurement of WMH in large-scale multisite clinical studies with heterogeneous patient populations remains challenging, where the diversity of imaging characteristics across studies adds additional complexity to this task. We present segcsvd
WMH, a convolutional neural network-based tool developed to provide reliable and accurate WMH quantification across diverse clinical datasets. segcsvd
WMH was developed using a large dataset consisting of over 700 fluid-attenuated inversion recovery MRI scans from seven multisite studies, spanning a wide range of clinical populations, WMH burdens, and imaging protocols. Model training incorporated anatomical information through a novel hierarchical segmentation approach, together with extensive data augmentation techniques to improve performance across varied imaging conditions. Benchmarked against three widely available segmentation tools, segcsvd
WMH demonstrated superior accuracy, achieving mean Dice score improvements of 7.8% ± 9.7% over HyperMapp3r, 21.8% ± 8.6% over SAMSEG, and 43.5% ± 7.1% over WMH-SynthSeg across four diverse test datasets. segcsvd
WMH also maintained consistently high Dice scores across these test datasets (mean DSC = 0.86 ± 0.08), and exhibited strong, stable correlations with periventricular, deep, and total WMH ground truth volumes (mean r = 0.99 ± 0.01). Additionally, segcsvd
WMH was robust to low and moderate levels of simulated MRI spike noise artifacts and maintained strong performance across a range of binary segmentation thresholds and WMH burden levels. These findings suggest that segcsvd
WMH may provide more accurate and robust WMH segmentation performance for heterogeneous clinical datasets characterized by varying degrees of CSVD severity.
KW - Humans
KW - Magnetic Resonance Imaging/methods
KW - White Matter/diagnostic imaging
KW - Aged
KW - Neural Networks, Computer
KW - Cerebral Small Vessel Diseases/diagnostic imaging
KW - Female
KW - Male
KW - Neuroimaging/methods
KW - Deep Learning
KW - Middle Aged
KW - Aged, 80 and over
KW - Cohort Studies
U2 - 10.1002/hbm.70104
DO - 10.1002/hbm.70104
M3 - Article
C2 - 39723488
SN - 1065-9471
VL - 45
SP - e70104
JO - Human Brain Mapping
JF - Human Brain Mapping
IS - 18
ER -